# clm_09536F600AFF

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: research_and_development  
value: 995,922,000 United States dollar  
valid_from: 2015-12-31  
valid_to: 2016-12-31  
published: 2016-02-16  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_070B60D12935  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals research and development: 995,922,000 United States dollar", as of 2015-12-31 (until 2016-12-31). Claim clm_09536F600AFF, https://asof.is/claim/clm_09536F600AFF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532016000067/0000875320-16-000067-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2015, filed 2016-02-16  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532016000067/0000875320-16-000067-index.htm (primary, SEC EDGAR 10-K FY2015, published 2016-02-16)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | research_and_development | 855,506,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_09536F600AFF](/claim/clm_09536F600AFF.md) | [clm_2F6A721A75E3](/claim/clm_2F6A721A75E3.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.